|
|
||||||||
1 Department of Physiology and Biophysics, Wright State University School of Medicine, Dayton, Ohio 45435; 2 School of Pharmacy, Kuwait University; and 3 Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta, Georgia 30912-2300
| |
ABSTRACT |
|---|
|
|
|---|
H2O2 is a reactive oxygen species that contracts or relaxes vascular smooth muscle, but the molecular basis of these effects remains obscure. We previously demonstrated that H2O2 opens the large-conductance, calcium- and voltage-activated (BKCa) potassium channel of coronary myocytes (2) and now report physiological and biochemical evidence that the effect of H2O2 on coronary smooth muscle involves the phospholipase A2 (PLA2)/arachidonic acid (AA) signaling cascades. H2O2 stimulation of BKCa channel activity was inhibited by arachidonyl trifluoromethyl ketone, an inhibitor of cytosolic PLA2. Furthermore, H2O2 stimulated release of [3H]AA from coronary myocytes, and exogenous AA mimicked the effect of H2O2 on BKCa channels. Inhibitors of protein kinase C activity attenuated the effect of H2O2 on BKCa channels, [3H]AA release, or intact coronary arteries. In addition, the effect of H2O2 or AA on BKCa channels was inhibited by blockers of lipoxygenase metabolism. In contrast, inhibitors of cyclooxygenase or cytochrome P-450 had no effect. We propose that H2O2 relaxes coronary arteries by stimulating BKCa channels via the PLA2/AA signaling cascade and that lipoxygenase metabolites mediate this response.
hydrogen peroxide; calcium- and voltage-activated channels; phospholipase A2
| |
INTRODUCTION |
|---|
|
|
|---|
REACTIVE OXYGEN SPECIES, like H2O2, have been implicated in the pathophysiology of a variety of cardiovascular disorders such as ischemia-reperfusion injury, myocardial stunning, stroke, and obstructive airway disease (13). Recent clinical evidence indicates that H2O2 is produced in human plasma at micromolar concentrations and that plasma from hypertensive individuals contains higher levels of H2O2 than plasma from normotensive individuals (22). These studies suggest that H2O2 is a pathophysiological substance that contributes to essential hypertension and its associated sequelae (e.g., atherosclerosis, myocardial infarction, stroke). In contrast, H2O2 also produces beneficial effects on the cardiovascular system and other tissues. For example, H2O2 was administered intravenously as an anticancer agent over 30 years ago (32). More recently, H2O2 has been shown to relax pulmonary (4), cerebral (35, 39), or coronary (2, 26) arteries and to significantly enhance postischemic functional recovery and coronary blood flow in isolated hearts (15, 34). These studies imply that H2O2 can act as either a physiological or a pathophysiological substance, but the basis of this interesting conundrum remains obscure. We are only beginning to understand the cellular and/or molecular basis of H2O2 action, particularly its effects on the heart and blood vessels.
We recently demonstrated that physiological concentrations of H2O2 relax porcine coronary arteries via an endothelium-independent mechanism involving activity of the large-conductance, calcium- and voltage-activated potassium (BKCa) channel in coronary smooth muscle cells (2). This study further suggested that H2O2-induced coronary relaxation might involve arachidonic acid (AA) production. The goal of the present study was to characterize this potential H2O2 transduction mechanism in coronary smooth muscle cells and relate these cellular findings to the effect of H2O2 on coronary artery function. We now provide direct biochemical and electrophysiological evidence that H2O2 stimulates a cellular transduction cascade, i.e., phospholipase A2 (PLA2) activity and AA production, to open BKCa channels in coronary smooth muscle and promote relaxation. Evidence is also presented that this effect of H2O2 involves stimulation of protein kinase C (PKC) activity and lipoxygenase metabolism but does not require activity of the cyclooxygenase or P-450 cascades. We propose that vascular effects of H2O2, and possibly other reactive oxygen species, involve the PLA2/AA signaling cascade in vascular smooth muscle cells and that stimulation of potassium channel activity can mediate the vasodilatory response to these agents.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cell isolation. Myocytes were isolated by a modification of a procedure described previously (2). Briefly, fresh porcine hearts were obtained from a local abattoir. The left anterior descending coronary artery (LAD) was excised and placed in ice-cold dissociation medium of the following composition (in mM): 110.0 NaCl, 5.0 KCl, 2.0 MgCl2, 0.16 CaCl2, 10.0 HEPES, 10.0 NaHCO3, 0.5 KH2PO4, 0.5 NaH2PO4, 0.49 EDTA, 10.0 taurine, and 10.0 glucose, pH 6.9. Arteries were kept on ice during transport to the laboratory. The LAD was cleaned of adherent fat and connective tissue under a dissecting microscope, and the adventitia was carefully dissected away. Each artery was then cut into 1-mm strips and placed in test tubes containing dissociation medium as described above. Media strips were incubated at 37°C in 5 ml of dissociation medium with 5.0 mg papain, 2.3 mM dithiothreitol (DTT), and 0.2% BSA for 30 min. Afterward, the tissue was triturated, and the enzyme activity was diluted by adding excess enzyme-free solution. The solution was removed and centrifuged at 500 g for 6 min at 4°C. The pellet was then resuspended in fresh medium and kept at 4°C. Experiments were performed within 6-8 h after cell dissociation.
Patch-clamp studies.
For cell-attached patches, several drops of cell suspension were
placed in a recording chamber (Warner Instruments) containing a
solution of the following composition (in mM): 140 KCl, 10 MgCl2, 0.1 CaCl2, 10 HEPES, and 30 glucose (pH
7.4; 22-25°C). Single potassium channels were measured in
cell-attached patches by filling the patch pipette (2-5 M
) with
Ringer solution (in mM: 140 NaCl, 5 KCl, 1 MgCl2, 2 CaCl2, and 10 HEPES) and making a gigaohm seal on a single
myocyte. Voltage across the patch was controlled by clamping the cell
at 0 mV with the high-concentration extracellular potassium solution.
Currents were filtered at 2 kHz and digitized at 10 kHz. Average
channel activity (NPo) in patches with multiple BKCa channels was determined as described previously
(40). For consistency, statistics on channel activity were
reported at a membrane potential of +40 mV. Although the effect of
H2O2 and other agents was observed at a variety
of potentials, BKCa channels are very clearly identified at
+40 mV thus increasing the accuracy and reliability of NPo
calculations. Previous studies from our laboratory (14,
40) and others (9, 41) commonly
record BKCa channel activity at such potentials. In
experiments recording potassium channel activity of inside-out patches,
the bathing solution exposed to the cytoplasmic surface of the membrane
consisted of the following low-calcium solution (in mM): 60 K2SO4, 30 KCl, 2 MgCl2, 1 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid,
0.16 CaCl2 (pCa 7), 10 HEPES, 5 ATP, and 10 glucose (pH 7.4; 22-25°C).
Arterial tension studies.
Arterial rings (4-5 mm in length, 2-4 mm in diameter) were
obtained from each LAD and were prepared for isometric contractile force recordings as described previously (40).
H2O2 induces endothelium-independent relaxation
of porcine coronary arteries (2); therefore, to control
for possible indirect effects of endothelium-derived vasoactive
factors, the endothelium was removed by rubbing the intimal surface.
Rings were mounted between two triangular tissue supports with one
fixed to the bottom of the tissue bath and the other attached to a
force-displacement transducer, and contractile force (grams) was
recorded on a computer every 3 s. The tissue bathing solution was
a modified Krebs-Henseleit buffer of the following composition (in mM):
118.0 NaCl, 4.8 KCl, 1.2 MgCl2, 2.5 CaCl2, 25.0 NaHCO3, 1.2 KH2PO4, and 11.0 glucose, pH 7.4. This solution was continuously oxygenated (97%
O2-3% CO2) and heated to 37°C. Coronary ring
preparations were equilibrated for 90 min under an optimal resting
tension of 2.0 grams, and fresh solution was added every 30 min. After
equilibration, preparations were exposed to contractile agent
(5-10 µM PGF2
) that maximally contracted the
arteries and ensured stabilization of the muscle. After agonist removal
and reequilibration (30 min), the contractile agent was reapplied to
the tissue bath, and when the tissue reached a stable maximum
contraction, H2O2 was added to the bathing
medium. Each day, one tissue was contracted with PGF2
but was not exposed to H2O2 to control for
possible "fading" of the contractile response. Tissues were
incubated with inhibitors of AA metabolism at least 30 min before
H2O2 exposure. All drug solutions were prepared
fresh daily.
AA assay. Myocytes were isolated by the procedure described above, except that multiple tissue samples were dissociated concurrently, and the final cell suspensions were pooled. An aliquot of each suspension was examined microscopically to assess possible contamination with nonsmooth muscle cells. All cells were incubated at 37°C for 2 h with 20 µCi of tritiated AA ([3H]AA) in dissociation medium, after which the medium was removed and the cells were washed three to four times with cold Krebs-Henseleit buffer. After the final wash, cells were resuspended in 0.2% fatty acid-free BSA and then divided into l-ml aliquots in microfuge tubes. The cells then were incubated in a 37°C water bath for 15 min, after which H2O2 was added to each vial to a final concentration of either 100, 300, or 1,000 µM. Tubes were again incubated in a 37°C water bath for 15 min and then were placed on ice for 10 min to stop all reactions. Tubes were then centrifuged at high speed, 900 µl were transferred (remaining 100 µl was saved for protein determination) to labeled glass tubes, and two times the volume (1.8 ml) of a 2:1 vol/vol solution of chloroform-methanol (CHCl3/CH3OH) was added. Tubes were vortexed and centrifuged at high speed, and the lower chloroform layer was removed. The chloroform layer was evaporated overnight under vacuum, leaving a thin white residue. Silicic acid columns were prepared by adding 0.5 g silicic acid to glass- and wool-plugged Pasteur pipettes supported in a rack. Each column was washed with 10 ml petroleum ether (60-80°C) before use. The samples were dissolved in 1 ml petroleum ether-diethyl ether (96:4 vol/vol) and then were applied to a column, which was then washed with 3 ml petroleum ether-diethyl ether and 3 ml diethyl ether to elute the [3H]AA from the column. The diethyl ether was collected in a scintillation vial to which was added 10 ml Scintiverse II and then was counted at 5-min counts on a scintillation counter preprogrammed for beta emission. AA generation was normalized for total amount of protein per sample after Lowry (25) protein determination.
Drugs.
AA, papain, indomethacin, DTT, proadifen, eicosatrienoic acid (ETI),
sodium nitroprusside, BSA, baicalein, and PGF2
were purchased from Sigma Chemical. H2O2 and
Scintiverse II were purchased from Fisher Scientific. MK-886 and
calphostin C were purchased from Calbiochem. Arachidonyl
trifluoromethyl ketone (ATK) and sphingosine were purchased from
Research Biochemicals International, and [3H]AA was
purchased from Amersham.
Statistical analysis. Data from tissue studies were expressed as the percentage of maximum relaxation, and all other data were expressed as means ± SE. Statistical significance between two groups was evaluated by Student's t-test for paired data. Comparison between multiple groups was made by the one-way ANOVA test, with a post hoc Tukey's test to determine significant differences among the data groups. P < 0.05 was considered to indicate a significant difference.
| |
RESULTS |
|---|
|
|
|---|
H2O2 opens BKCa channels via
second messengers.
Exposing cells to H2O2 stimulated activity of a
large-amplitude channel isolated in cell-attached patches (Fig.
1A). On average, single-channel open probability (NPo) increased from ~0
to 0.532 ± 0.07 (+40 mV, n = 8) after 20-30
min exposure to 300 µM H2O2. This
concentration of H2O2 is near the
EC50 value for H2O2-induced relaxation of porcine coronary arteries (2) and is a
physiological concentration (37). In contrast to its
effect on intact cells, H2O2 did not affect
channel activity when superfused on the cytoplasmic surface of
inside-out membrane patches (Fig. 1B; n = 4). In the same excised patch, however, channel activity was stimulated
dramatically by increasing "intracellular" calcium concentration
from 0.1 to 100 µM (NPo from 0.11 ± 0.01 to
0.76 ± 0.11 at +40 mV; n = 4). Single-channel
current-voltage relationships indicated that the H2O2- and calcium-sensitive channel exhibited a
conductance of >100 pS in physiological K+ gradients and
was sensitive to blockade by 1 mM tetraethylammonium (TEA; data not
shown). Because of this high conductance and sensitivity to elevated
intracellular calcium levels and TEA, we have identified this protein
as the BKCa channel that we and others have characterized previously in these and other identical cells (e.g., see Refs. 9, 12,
14, 40, 41). In addition, the reducing agents glutathione (1 mM) or DTT
(1 mM) completely prevented the stimulatory effect of
H2O2 on BKCa channel activity
(n = 5-9; P < 0.0001; data not
shown).
|
, 300 µM
H2O2 produced the expected relaxation response
(68 ± 7%; n = 4). In contrast, when the same
artery was precontracted with a low concentration (1 mM) of TEA, 300 µM H2O2 produced significantly less
relaxation (39 ± 2%; n = 4; P < 0.02), and this diminished response was prolonged dramatically. TEA
exhibits selectivity for BKCa channels at this concentration. These results are consistent with our previous findings
that H2O2-induced coronary relaxation involves
potassium efflux (2). Our patch-clamp studies revealed
that H2O2 stimulated BKCa channels
only in on-cell patches from intact cells; therefore, these studies
suggested that a second messenger signaling cascade was stimulated by
H2O2 in coronary myocytes. Subsequent studies characterized this transduction mechanism.
|
H2O2 stimulates the PLA2-AA
cascade in coronary smooth muscle.
Previous studies have indicated that H2O2 can
activate PLA2 in vascular smooth muscle (28).
To test this possibility in coronary arteries, we employed ATK, which
selectively inhibits cytosolic PLA2 (36). In
four out of four cell-attached patches, ATK reversed the stimulatory
effect of H2O2 on BKCa channel
activity by an average of 97 ± 8% (Fig.
3). As expected, 300 µM
H2O2 stimulated channel NPo from
0.003 ± 0.003 to 0.498 ± 0.176 (+40 mV), but channel
NPo was reduced to 0.013 ± 0.013 by 15 µM ATK (20 min; P < 0.05). In contrast, ATK had no direct
inhibitory effect on channel activity in inside-out patches
(n = 3, data not shown). These findings suggested that
H2O2 opens BKCa channels via
stimulation of PLA2 activity, and further experiments were
performed to verify this conclusion directly.
|
|
|
|
Lipoxygenase metabolites mediate the effect of
H2O2 and AA on coronary arteries.
Studies on single myocytes and intact arteries were performed to
characterize the downstream events of AA metabolism that mediated the
effect of H2O2. Studies on cell-attached
patches revealed that the stimulatory effect of
H2O2 on BKCa channel activity was
reversed by inhibitors of lipoxygenase activity. We employed three
different agents that are known to inhibit lipoxygenase: ETI, a general
inhibitor of lipoxygenase pathways (27); MK-886, which
specifically inhibits the 5-lipoxygenase activating protein (31); and baicalein, an inhibitor of 12-lipoxygenase
(27). Each of these inhibitors was effective in reversing
the effect of H2O2/AA on BKCa
channels in cell-attached patches. We reported previously that 5 µM
ETI reversed the effect of H2O2 on channel activity (2) and now demonstrate that ETI produces a
similar inhibition of AA-stimulated channel activity (Fig.
6A). On average, BKCa channel NPo
stimulated by 10 µM AA was reversed 60% 30 min after treatment with
5 µM ETI (from 0.529 ± 0.04 to 0.217 ± 0.025 at +40 mV;
n = 4; P = 0.003). To control for
potential nonspecific effects of ETI, the ability of this lipoxygenase
inhibitor to inhibit nitrovasodilator-induced coronary relaxation was
also examined. In arteries precontracted with 5 µM
PGF2
, 10 µM sodium nitroprusside induced a nearly
complete (91 ± 2%; n = 4; Fig. 6B)
relaxation. After a 30-min incubation with 5 µM ETI, nitroprusside
produced an almost identical response (89 ± 2%; n = 4; Fig. 6B). Because ETI neither blocks
BKCa channels directly (n = 4 out of 4 inside-out patches) nor affects nitrovasodilator-induced coronary
relaxation, we conclude that H2O2-induced
BKCa channel activity involves the lipoxygenase signaling pathway.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
H2O2 is recognized as an important intracellular signaling trigger that activates a variety of signal transduction systems, including PKC (6), PLA2 (7, 28), nitric oxide (8), guanylyl cyclase (4), and cyclooxygenase (30), in a variety of cell types. Interestingly, H2O2 is also a vasoactive agent that can either relax (35) or contract (29) blood vessels, and recent clinical studies have revealed that plasma levels of H2O2 correlate with the incidence of essential hypertension (22). On the other hand, H2O2 exerts "beneficial" vasodilatory effects on the coronary (26, 34) and cerebral (35) circulations. Moreover, H2O2 can either contract or relax porcine coronary arteries, and these responses do not involve stimulation of guanylyl cyclase or cGMP (2). In light of these somewhat contradictory findings, it is clear that our understanding of the cellular and/or molecular basis of H2O2 effects on blood vessels is far from complete. The present study now combines evidence from biochemical, pharmacological, and single-channel patch-clamp experiments to strongly suggest that H2O2 opens BKCa channels in single coronary myocytes via a mechanism involving PKC stimulation of the PLA2-AA-lipoxygenase signaling pathway.
Because of their large conductance and high density of expression,
BKCa channels appear to be the predominant potassium
channel of both porcine (40) and human (12)
coronary arteries. Opening of these channels produces a powerful
repolarizing action that closes voltage-dependent calcium channels to
induce vascular relaxation. Previous studies suggested that
H2O2 increased potassium conductance in various
cell types, including renal epithelial cells (11), pyramidal neurons (33), pancreatic
-cells
(20), and lung adenocarcinoma cells (21). The
important role of potassium channels in mediating
H2O2-induced vasorelaxation has been suggested
by observations that the relaxation response to
H2O2 is abolished in aorta (17) or
coronary arteries (2) precontracted by high extracellular
potassium concentration, which reduces the driving force for potassium
efflux. However, no single-channel studies had identified a specific
potassium channel opened by H2O2 in vascular
smooth muscle cells. Findings from the present study confirm our
previous report that H2O2 opens
BKCa channels in coronary smooth muscle (2).
Because it can easily cross cell membranes, it was possible that
H2O2 was interacting directly with channel proteins; however, H2O2 did not affect channels
in cell-free patches (Fig. 1B). These findings indicate that
H2O2 stimulates a second messenger process in
coronary smooth muscle cells. Identification of the BKCa
channel as a target of H2O2 action allowed us
to employ this protein as a sensitive molecular assay to investigate
the importance of signaling mechanisms stimulated by
H2O2 in coronary smooth muscle.
H2O2 activates cytosolic PLA2 in cultured aortic smooth muscle cells (28), but this mechanism has not been investigated in primary cells from coronary arteries. Involvement of PLA2 in the response to H2O2 was investigated by several means. First, patch-clamp studies indicated that inhibition of cytosolic PLA2 activity by a selective inhibitor, ATK (36), reversed the effect of H2O2 on BKCa channel activity. In addition, the same stimulatory concentrations of H2O2 that opened BKCa channels also induced [3H]AA release from coronary myocytes, confirming involvement of PLA2 in the response to H2O2. Furthermore, if AA was indeed a cellular messenger for H2O2 effects, then exogenous AA should mimic the stimulatory effect of H2O2. Subsequent patch-clamp studies revealed that direct application of AA to coronary myocytes stimulated the activity of BKCa channels, as did H2O2. Stimulation of BKCa channels by AA was reversed by ETI, indicating that AA, like H2O2, does not affect channel proteins directly. Because ETI did not affect nitroprusside-induced coronary relaxation, the likelihood that ETI produces significant nonspecific effects (e.g., on calcium levels, contractile proteins, channel blockade) appears remote. In light of this evidence from both functional studies and biochemical measurements, we conclude that H2O2-induced stimulation of BKCa channel activity involves PLA2 activity and release of AA from membrane lipids in coronary artery smooth muscle. PLA2 has been classified as either secretory or cytosolic, and evidence indicates that the cytosolic form is the agonist-stimulated PLA2 (10), which is also stimulated by H2O2 in endothelial (3) or aortic smooth muscle cells (28).
There is increasing evidence that PLA2 activity is regulated by a number of cellular mechanisms, including PKC, mitogen-activated protein (MAP) kinase, and possibly G proteins (23). The present study provides evidence suggesting that the effect of H2O2 on coronary arteries may also involve PKC. The stimulatory effect of H2O2 on either BKCa channel activity or [3H]AA release from coronary smooth muscle was antagonized by sphingosine, an inhibitor of PKC activity. Furthermore, a more selective inhibitor of PKC activity, calphostin C, was even more effective (94%) at attenuating H2O2-induced relaxation of coronary arteries. In addition to these experiments with PKC antagonists, experiments were performed on arteries pretreated with phorbol ester. Such pretreatment is known to downregulate PKC activity, and results from these studies indicated that the relaxant effect of H2O2 was significantly depressed in TPA-treated arteries. These findings from four different types of experiments on coronary myocytes and intact arteries are consistent with a H2O2 transduction pathway involving PKC stimulation of PLA2 activity. Previous studies have also reported that PKC inhibitors depress H2O2-induced AA release in other cell types (3). PKC phosphorylates PLA2 in vitro (24), but at present there is limited evidence that PKC phosphorylates PLA2 directly in vivo (23). An alternative explanation for the present results could be that the immediate substrate for H2O2-stimulated PKC is actually MAP kinase, which activates (phosphorylates) cytosolic PLA2 in other cell types (24). H2O2 stimulates MAP kinase activity in perfused rat hearts (18) and pulmonary artery smooth muscle (42) but may (28) or may not stimulate this enzyme in rat aorta (1). Therefore, the action of H2O2 on MAP kinase activity might be heterogeneous with respect to artery and/or species. Although the present findings argue for PKC involvement in the response of coronary arteries to H2O2, the specific isoform(s) remains to be identified. Also, it is still unclear whether MAP kinase is involved as an intermediary component of this signaling cascade. However, the present findings demonstrate that inhibitors of PKC activity completely reversed H2O2-induced release of [3H]AA (Fig. 4) and significantly depressed H2O2-stimulated BKCa channel activity or relaxation of coronary arteries. Therefore, it seems unlikely that H2O2 acts independently of PKC and exclusively through MAP kinase, but further studies are necessary to help resolve this issue.
The present findings indicate that both H2O2-induced coronary relaxation and stimulation of BKCa channel activity in single myocytes are mediated via lipoxygenase metabolites of AA. The present study provides substantial pharmacological support for this conclusion, but it is recognized that few of the agents employed are completely selective. However, these pharmacological studies are further supported by direct biochemical measurement of H2O2-stimulated [3H]AA release from coronary myocytes and the fact that exogenous AA mimics the effect of H2O2 on BKCa channel activity. Furthermore, we had demonstrated previously that H2O2 induces contraction of porcine coronary arteries via cyclooxygenase metabolites of AA (2). Therefore, we conclude that H2O2-induced stimulation of BKCa channel activity involves AA metabolism, most likely via lipoxygenase activity. Although involvement of lipoxygenase metabolites has not been established unequivocally, it is known that lipoxygenase metabolism underlies AA stimulation of BKCa channel activity in neuroendocrine (9) and chromaffin (38) cells. Other studies of vascular smooth muscle indicate that metabolites of cytochrome P-450 epoxygenase, possibly acting as endothelium-derived hyperpolarizing factors, stimulate BKCa channel activity in portal vein, caudal artery, aorta, and coronary artery (16); however, such epoxyeicosatrienoic acids are not synthesized by smooth muscle cells (5). Furthermore, we found that inhibitors of the P-450 or cyclooxygenase cascades did not affect H2O2-induced coronary relaxation (Fig. 8). Thus the present findings, as well as and those from other studies, indicate that there are pleotropic effects of AA metabolism on vascular smooth muscle excitability, and, in some cases, even divergent responses in the same vessel. For example, we propose that a single signaling pathway, stimulation of AA metabolism, can now account for the interesting observation that H2O2 can induce either relaxation or contraction (2) in the same artery. Further studies are required to identify a specific lipoxygenase(s) that mediates the response to H2O2.
We propose that H2O2 can either contract or relax porcine coronary arteries by stimulating the PLA2/AA transduction pathway. Coronary relaxation mediated by BKCa channel activity occurs when lipoxygenase metabolism of AA predominates, but contraction can be induced when AA is metabolized primarily by cyclooxygenase. Because H2O2 affects different arteries in different ways, it may be premature to assume that H2O2 must be a pathogenic agent in the etiology of essential hypertension, simply because plasma levels are elevated (22). Elevated H2O2 might also be compensatory under certain conditions. In light of our findings (and those of others), we propose that a key to understanding the role of H2O2 in regulating vascular smooth muscle tone depends on the disposition of AA metabolism. Because circulating and/or tissue levels of free AA or other fatty acids increase during pathological states (e.g., ischemia, stroke, diabetes), understanding the molecular basis of how these compounds affect vascular smooth muscle and other cells will continue to be an important emphasis of future studies.
| |
ACKNOWLEDGEMENTS |
|---|
We thank A. Barlow, Z. Barlow, and M. White for continued moral support and M. Barlow for more recent contributions. We are also grateful to Landes Meats and Bob Evan's Farms for kind cooperation and to V. Deenadayalu, J. Kryman, and P. McMillin for technical support.
| |
FOOTNOTES |
|---|
This work was supported by National Heart, Lung, and Blood Institute Grant HL-54844 and by the American Heart Association.
Address for reprint requests and other correspondence: R. E. White, Dept. of Pharmacology & Toxicology, Medical College of Georgia, Augusta, GA 30912-2300 (E-mail: rwhite{at}mail.mcg.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Received 16 June 1999; accepted in final form 26 January 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Baas, AS,
and
Berk BC.
Differential activation of mitogen-activated protein kinases by H2O2 and O2- in vascular smooth muscle cells.
Circ Res
77:
29-36,
1995
2.
Barlow, RS,
and
White RE.
Hydrogen peroxide relaxes porcine coronary arteries by stimulating BKCa channel activity.
Am J Physiol Heart Circ Physiol
275:
H1283-H1289,
1998
3.
Boyer, CS,
Bannenberg GL,
Neve EPA,
Ryrfeldt A,
and
Moldeus P.
Evidence for the acitvation of the signal-responsive phospholipase A2 by exogenous hydrogen peroxide.
Biochem Pharmacol
50:
753-761,
1995[ISI][Medline].
4.
Burke, TM,
and
Wolin MS.
Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation.
Am J Physiol Heart Circ Physiol
252:
H721-H732,
1987
5.
Campbell, WB,
and
Harder DR.
Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone.
Circ Res
84:
484-488,
1999
6.
Chakraborti, S,
and
Chakraborti T.
Down-reglation of protein kinase C attenuates the oxidant hydrogen peroxide-mediated activation of phospholipase A2 in pulmonary vascular smooth muscle cells.
Cell Signal
7:
75-83,
1995[ISI][Medline].
7.
Chakraborti, S,
and
Michael JR.
Role of protein kinase C in oxidant-mediated activation of phospholipase A2 in rabbit pulmonary arterial smooth muscle cells.
Mol Cell Biochem
122:
9-15,
1993[ISI][Medline].
8.
Cosentino, F,
and
Katusic ZS.
Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries.
Circulation
91:
139-144,
1995
9.
Duerson, K,
White RE,
Jiang F,
Schonbrunn A,
and
Armstrong DL.
Somatostatin stimulates BKCa channels in rat pituitary tumor cells through lipoxygenase metabolites of arachidonic acid.
Neuropharmacology
35:
949-961,
1996[ISI][Medline].
10.
Exton, JH.
Phospholipid-derived second messengers.
In: Handbook of Physiology: Cellular Endocrinology. Bethesda, MD: Am Physiol Soc, 1998, sect. 7, vol. I, chapt. 11, p. 255-291.
11.
Filipovic, DM,
and
Reeves WB.
Hydrogen peroxide activates glibenclamide-sensitive K+ channels in LLC-PK1 cells.
Am J Physiol Cell Physiol
272:
C737-C743,
1997
12.
Gollasch, M,
Ried C,
Bychkov R,
Luft FC,
and
Haller H.
K+ currents in human coronary artery vascular smooth muscle cells.
Circ Res
78:
676-688,
1996
13.
Halliwell, B.
The role of oxygen radicals in human disease, with particular reference to the vascular system.
Haemostasis
1:
118-126,
1993.
14.
Han, G,
Kryman JP,
McMillin PJP,
White RE,
and
Carrier GO.
Dopamine relaxes coronary arteries by opening BKCa channels via the cyclic GMP-dependent protein kinase.
J Cardiovasc Pharmacol
34:
619-627,
1999[ISI][Medline].
15.
Hegstad, AC,
Antonsen OH,
and
Ytrehus K.
Low concentrations of hydrogen peroxide improve post-ischaemic metabolic and functional recovery in isolated perfused rat hearts.
J Mol Cell Cardiol
29:
2779-2787,
1997[ISI][Medline].
16.
Hu, S,
and
Kim HS.
Activation of K+ channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid.
Eur J Pharmacol
230:
215-21,
1993[ISI][Medline].
17.
Iesaki, T,
Okada T,
Yamaguchi H,
and
Ochi R.
Inhibition of vasoactive amine induced contractions of vascular smooth muscle by hydrogen peroxide in rabbit aorta.
Cardiovasc Res
28:
963-968,
1994[ISI][Medline].
18.
Knight, RJ,
and
Buxton DB.
Stimulation of c-Jun kinase and mitogen-activated protein kinase by ischemia and reperfusion in the perfused rat heart.
Biochem Biophys Res Commun
218:
83-88,
1996[ISI][Medline].
19.
Kobayashi, E,
Nakano H,
Morimoto M,
and
Tamaoki T.
Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent specific inhibitor of protein kinase C.
Biochem Biophys Res Commun
159:
548-553,
1989[ISI][Medline].
20.
Krippeit-Drews, P,
Lang F,
Haussinger D,
and
Drews G.
H2O2 induced hyperpolarization of pancreatic
-cells.
Pflügers Arch
426:
552-554,
1994[ISI][Medline].
21.
Kuo, SS,
Saad AH,
Koong AC,
Hahn GM,
and
Giaccia AJ.
Potassium-channel activation in response to low doses of gamma-irradiation involves reactive oxygen intermediates in nonexcitatory cells.
Proc Natl Acad Sci USA
90:
908-912,
1993
22.
Lacy, F,
O'Connor DT,
and
Schmid-Schoenbein GW.
Plasma hydrogen peroxide production in hypetensives and normotensive subjects at genetic risk of hypertension.
J Hypertens
16:
291-303,
1998[ISI][Medline].
23.
Leslie, CC.
Properties and regulation of cytosolic phospholipase A2.
J Biol Chem
272:
16709-16712,
1997
24.
Lin, L,
Lin AY,
and
Knopf JL.
Cytosolic phospholipase A2 is coupled to hormonally regulated release of arachidonic acid.
Proc Natl Acad Sci USA
889:
6146-6151,
1992.
25.
Lowry, OH,
Rosebrough NJ,
Farr AL,
and
Randall R.
Protein measurement with the Folin phenol reagent.
J Biol Chem
193:
265-275,
1951
26.
Olson, RD,
and
Boerth RC.
Hydrogen peroxide: beneficial effects in rabbits following acute coronary occlusion.
Am J Physiol Heart Circ Physiol
234:
H28-H34,
1978.
27.
Piomelli, D,
and
Greengard P.
Lipoxygenase metabolites of arachidonic acid in neuronal transmembrane signalling.
Trends Pharmacol Sci
11:
367-373,
1990[Medline].
28.
Rao, GN,
Runge MS,
and
Alexander RW.
Hydrogen peroxide activation of cytosolic phospholipase A2 in vascular smooth muscle cells.
Biochim Biophys Acta
1265:
67-72,
1995[Medline].
29.
Rhoades, RA,
Packer CS,
Roepke DA,
Jin N,
and
Meiss RA.
Reactive oxygen species alter contractile properties of pulmonary arterial smooth muscle.
Can J Physiol Pharmacol
68:
1581-1589,
1990[ISI][Medline].
30.
Rhoden, KJ,
and
Barnes PJ.
Effect of hydrogen peroxide on guinea-pig tracheal smooth muscle in vitro: role of cyclo-oxygenase and airway epithelium.
Br J Pharmacol
98:
325-330,
1989[ISI][Medline].
31.
Rouzer, CA,
Ford-Hutchinson AW,
Morton HE,
and
Gillard JW.
MK-886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes.
J Biol Chem
265:
1436-1442,
1990
32.
Sasaki, H,
Wakutani T,
Oda S,
and
Yamasaki Y.
Application of hydrogen peroxide infusion to maxillary cancer.
Yonago Acta Med
11:
141-149,
1967[ISI][Medline].
33.
Seutin, V,
Scuvee-Moreau J,
Massotte L,
and
Dresse A.
Hydrogen peroxide hyperpolarizes rat CA1 pyramidal neurons by inducing an increase in potassium conductance.
Brain Res
683:
275-278,
1995[ISI][Medline].
34.
Shattock, MJ,
Manning AS,
and
Hearse DJ.
Effects of hydrogen peroxide on cardiac function and post-ischaemic functional recovery in the isolated "working" rat heart.
Pharmacology
24:
118-122,
1982[ISI][Medline].
35.
Sobey, CG,
Heistad DD,
and
Faraci FM.
Mechanisms of bradykinin-induced cerebral vasodilatation in rats. Evidence that reactive oxygen species activate K+ channels.
Stroke
28:
2290-2294,
1997
36.
Street, IP,
Lin HK,
Laliberte F,
Ghomashci F,
Wang Z,
Perrier H,
Tremblay NM,
Huang Z,
Weech PK,
and
Gelb MH.
Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2.
Biochemistry
32:
5935-5940,
1993[Medline].
37.
Suematsu, M,
Schmid-Schonbein GW,
Chavez-Chavez RH,
Yee TT,
Tamatani T,
Miyasaka M,
Delano FA,
and
Zweifach BW.
In vivo visualization of oxidative changes in microvessels during neutrophil activation.
Am J Physiol Heart Circ Physiol
264:
H881-H891,
1993
38.
Twitchell, WA,
Pena TL,
and
Rane SG.
Ca2+-dependent K+ channels in bovine adrenal chromaffin cells are modulated by lipoxygenase metabolites of arachidonic acid.
J Membr Biol
158:
69-75,
1997[ISI][Medline].
39.
Wei, EP,
Kontos HA,
and
Beckman JS.
Mechanisms of cerebral vasodilation by superoxide, hydrogen peroxide, and peroxynitrite.
Am J Physiol Heart Circ Physiol
271:
H1262-H1266,
1996
40.
White, RE,
Darkow DJ,
and
Falvo Lang JL.
Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism.
Circ Res
77:
936-942,
1995
41.
Zhang, H,
Li P,
Almassi GH,
Nicolosi A,
Olinger GN,
and
Rusch NJ.
Single-channel and functional characteristics of a KCa channel in vascular muscle membranes of human saphenous veins.
J Cardiovasc Pharmacol
28:
611-617,
1996[ISI][Medline].
42.
Zhang, J,
Jin N,
Liu Y,
and
Rhoades RA.
Hydrogen peroxide stimulates extracellular signal-regulated protein kinases in pulmonary arterial smooth muscle cells.
Am J Respir Cell Mol Biol
19:
324-332,
1998
This article has been cited by other articles:
![]() |
D.-L. Dong, Y. Zhang, D.-H. Lin, J. Chen, S. Patschan, M. S. Goligorsky, A. Nasjletti, B.-F. Yang, and W.-H. Wang Carbon Monoxide Stimulates the Ca2+ Activated Big Conductance K Channels in Cultured Human Endothelial Cells Hypertension, October 1, 2007; 50(4): 643 - 651. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Rogers, W. M. Chilian, I. N. Bratz, R. M. Bryan Jr., and G. M. Dick H2O2 activates redox- and 4-aminopyridine-sensitive Kv channels in coronary vascular smooth muscle Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1404 - H1411. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Rogers, G. M. Dick, J. D. Knudson, M. Focardi, I. N. Bratz, A. N. Swafford Jr., S.-i. Saitoh, J. D. Tune, and W. M. Chilian H2O2-induced redox-sensitive coronary vasodilation is mediated by 4-aminopyridine-sensitive K+ channels Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2473 - H2482. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ardanaz and P. J. Pagano Hydrogen peroxide as a paracrine vascular mediator: regulation and signaling leading to dysfunction. Experimental Biology and Medicine, March 1, 2006; 231(3): 237 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xu, X. Bian, S. W. Watts, and A. Hlavacova Activation of Vascular BK Channel by Tempol in DOCA-Salt Hypertensive Rats Hypertension, November 1, 2005; 46(5): 1154 - 1162. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Denson, J. Li, X. Wang, and D. C. Eaton Activation of BK Channels in GH3 Cells by a c-PLA2-Dependent G-Protein Signaling Pathway J Neurophysiol, June 1, 2005; 93(6): 3146 - 3156. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Santarelli, J. Chen, S. H. Heinemann, and T. Hoshi The {beta}1 Subunit Enhances Oxidative Regulation of Large-Conductance Calcium-activated K+ Channels J. Gen. Physiol., September 27, 2004; 124(4): 357 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cseko, Z. Bagi, and A. Koller Biphasic effect of hydrogen peroxide on skeletal muscle arteriolar tone via activation of endothelial and smooth muscle signaling pathways J Appl Physiol, September 1, 2004; 97(3): 1130 - 1137. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Thengchaisri and L. Kuo Hydrogen peroxide induces endothelium-dependent and -independent coronary arteriolar dilation: role of cyclooxygenase and potassium channels Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2255 - H2263. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Clarke, S. Petrou, J. V. Walsh Jr., and J. J. Singer Modulation of BKCa channel activity by fatty acids: structural requirements and mechanism of action Am J Physiol Cell Physiol, November 1, 2002; 283(5): C1441 - C1453. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Campbell and D. R. Harder Prologue: EDHF-what is it? Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2413 - H2416. [Full Text] [PDF] |
||||
![]() |
|